Mary Beth Harler
|
Director, Chief Executive Officer |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
323,680 |
0
(0%)
|
1%
|
|
-
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
330,700 |
0
(0%)
|
1%
|
|
-
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
22,222 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
29,806 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
29,807 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Julie Hambleton
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
2,000 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Michael Lee
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
12,712 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
William Strohl
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
125,000 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
10,400,564 |
0
(0%)
|
34%
|
|
-
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
54,235 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
9,800 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
5,044,295 |
0
|
-
|
|
-
|
Non-Voting Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
5,044,295 |
0
|
-
|
|
-
|
Non-Voting Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
10,400,564 |
0
(0%)
|
34%
|
|
-
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
91,712 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Elizabeth H.Z. Thompson
|
Director |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
14 Aug 2025 |
7,196 |
0
(0%)
|
0%
|
|
-
|
Common Stock |
Mary Beth Harler
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 1.27 per share. |
23 Jul 2025 |
14,501 |
323,680
(1%)
|
0%
|
1.3 |
18,457
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 1.27 per share. |
23 Jul 2025 |
8,741 |
170,061
(0%)
|
0%
|
1.3 |
11,126
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
Sale of securities on an exchange or to another person at price $ 1.27 per share. |
23 Jul 2025 |
4,409 |
68,169
(0%)
|
0%
|
1.3 |
5,612
|
Common Stock |
Elizabeth H.Z. Thompson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2025 |
694 |
7,196
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2025 |
828 |
91,712
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2025 |
1,284 |
54,235
(0%)
|
0%
|
|
0
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2025 |
1,471 |
22,222
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2025 |
828 |
12,712
(0%)
|
0%
|
|
0
|
Common Stock |
Mary Beth Harler
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 1.20 per share. |
16 Jun 2025 |
1,522 |
338,181
(1%)
|
0%
|
1.2 |
1,825
|
Common Stock |
Steven Weber T.
|
PRINCIPAL ACCOUNTING OFFICER |
Sale of securities on an exchange or to another person at price $ 1.20 per share. |
16 Jun 2025 |
486 |
26,530
(0%)
|
0%
|
1.2 |
583
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 1.20 per share. |
16 Jun 2025 |
1,522 |
178,802
(0%)
|
0%
|
1.2 |
1,825
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
Sale of securities on an exchange or to another person at price $ 1.20 per share. |
16 Jun 2025 |
951 |
72,578
(0%)
|
0%
|
1.2 |
1,140
|
Common Stock |
Steven Weber T.
|
PRINCIPAL ACCOUNTING OFFICER |
Sale of securities on an exchange or to another person at price $ 1.12 per share. |
14 May 2025 |
1,865 |
27,016
(0%)
|
0%
|
1.1 |
2,090
|
Common Stock |
Elizabeth H.Z. Thompson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
694 |
6,502
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
828 |
90,884
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
1,284 |
52,951
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
828 |
11,884
(0%)
|
0%
|
|
0
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2025 |
1,471 |
20,751
(0%)
|
0%
|
|
0
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
Sale of securities on an exchange or to another person at price $ 1.23 per share. |
14 Mar 2025 |
7,329 |
180,324
(0%)
|
0%
|
1.2 |
9,015
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
Sale of securities on an exchange or to another person at price $ 1.23 per share. |
14 Mar 2025 |
4,512 |
73,529
(0%)
|
0%
|
1.2 |
5,550
|
Common Stock |
Steven Weber T.
|
PRINCIPAL ACCOUNTING OFFICER |
Sale of securities on an exchange or to another person at price $ 1.23 per share. |
14 Mar 2025 |
1,701 |
28,881
(0%)
|
0%
|
1.2 |
2,092
|
Common Stock |
Mary Beth Harler
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 1.23 per share. |
14 Mar 2025 |
7,329 |
339,703
(1%)
|
0%
|
1.2 |
9,015
|
Common Stock |
Steven Weber T.
|
PRINCIPAL ACCOUNTING OFFICER |
Sale of securities on an exchange or to another person at price $ 1.70 per share. |
15 Jan 2025 |
1,122 |
30,582
(0%)
|
0%
|
1.7 |
1,907
|
Common Stock |
Elizabeth H.Z. Thompson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2024 |
1,452 |
5,808
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2024 |
1,734 |
90,056
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2024 |
2,687 |
51,667
(0%)
|
0%
|
|
0
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2024 |
3,078 |
19,280
(0%)
|
0%
|
|
0
|
Common Stock |
Lee Michael
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Dec 2024 |
1,734 |
11,056
(0%)
|
0%
|
|
0
|
Common Stock |
Steven Weber
|
PRINCIPAL ACCOUNTING OFFICER |
|
16 Dec 2024 |
539 |
31,704
(0%)
|
0%
|
7.5 |
4,032
|
Common Stock |
Lynn Lisa Decker
|
CHIEF BUSINESS OFFICER |
|
16 Dec 2024 |
1,063 |
78,041
(0%)
|
0%
|
7.5 |
7,951
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
16 Dec 2024 |
1,708 |
187,653
(0%)
|
0%
|
7.5 |
12,776
|
Common Stock |
Mary Beth Harler
|
Director, Chief Executive Officer |
Sale of securities on an exchange or to another person at price $ 7.48 per share. |
16 Dec 2024 |
1,708 |
347,032
(1%)
|
0%
|
7.5 |
12,776
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
18 Nov 2024 |
66,667 |
189,361
(0%)
|
0%
|
|
0
|
Common Stock |
Steven Weber
|
PRINCIPAL ACCOUNTING OFFICER |
|
07 Nov 2024 |
6,700 |
32,243
(0%)
|
0%
|
|
0
|
Common Stock |
Mary Beth Harler
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Oct 2024 |
370,000 |
370,000
|
-
|
|
-
|
Stock Option (right to buy) |
Mary Beth Harler
|
Director, Chief Executive Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
02 Oct 2024 |
185,000 |
348,740
(1%)
|
0%
|
|
0
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
3,078 |
16,202
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
1,734 |
9,322
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
2,687 |
48,980
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
1,734 |
88,322
(0%)
|
0%
|
|
0
|
Common Stock |
Elizabeth H.Z. Thompson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2024 |
1,452 |
4,356
(0%)
|
0%
|
|
0
|
Common Stock |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Sale of securities on an exchange or to another person at price $ 11.54 per share. |
13 Sep 2024 |
1,487 |
154,331
(0%)
|
0%
|
11.5 |
17,158
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
13 Sep 2024 |
925 |
79,104
(0%)
|
0%
|
11.5 |
10,673
|
Common Stock |
Fred Schwarzer
|
Director, CEO AND PRESIDENT |
Sale of securities on an exchange or to another person at price $ 11.54 per share. |
13 Sep 2024 |
3,946 |
250,124
(0%)
|
0%
|
11.5 |
45,532
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Sale of securities on an exchange or to another person at price $ 11.54 per share. |
13 Sep 2024 |
1,487 |
242,948
(0%)
|
0%
|
11.5 |
17,158
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
13 Sep 2024 |
1,487 |
122,694
(0%)
|
0%
|
11.5 |
17,158
|
Common Stock |
Steven Weber
|
PRINCIPAL ACCOUNTING OFFICER |
|
13 Sep 2024 |
469 |
25,543
(0%)
|
0%
|
11.5 |
5,412
|
Common Stock |
Mary Beth Harler
|
Head, Research & Autoimmunity |
Sale of securities on an exchange or to another person at price $ 11.54 per share. |
13 Sep 2024 |
1,487 |
163,740
(0%)
|
0%
|
11.5 |
17,158
|
Common Stock |
William Strohl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
08 Aug 2024 |
125,000 |
125,000
(0%)
|
0%
|
|
0
|
Common Stock |
Julie Hambleton
|
Director |
Sale of securities on an exchange or to another person at price $ 14.00 per share. |
25 Jul 2024 |
15,132 |
2,000
(0%)
|
0%
|
14 |
211,848
|
Common Stock |
Julie Hambleton
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
25 Jul 2024 |
15,132 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Julie Hambleton
|
Director |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
25 Jul 2024 |
15,132 |
17,132
(0%)
|
0%
|
1.4 |
21,033
|
Common Stock |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Jul 2024 |
150,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Jul 2024 |
43,750 |
139,568
(0%)
|
0%
|
|
-
|
Common Stock |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Jul 2024 |
16,250 |
155,818
(0%)
|
0%
|
|
-
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
19 Jul 2024 |
16,666 |
76,695
(0%)
|
0%
|
|
-
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
19 Jul 2024 |
60,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
19 Jul 2024 |
3,334 |
80,029
(0%)
|
0%
|
|
-
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Jul 2024 |
75,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Jul 2024 |
2,778 |
244,435
(0%)
|
0%
|
|
-
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Jul 2024 |
43,888 |
241,657
(0%)
|
0%
|
|
-
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Jul 2024 |
50,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
19 Jul 2024 |
40,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
19 Jul 2024 |
33,111 |
121,959
(0%)
|
0%
|
|
-
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
19 Jul 2024 |
2,222 |
124,181
(0%)
|
0%
|
|
-
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
19 Jul 2024 |
55,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Mary Beth Harler
|
Head, Research & Autoimmunity |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Jul 2024 |
25,001 |
165,227
(0%)
|
0%
|
|
-
|
Common Stock |
Mary Beth Harler
|
Head, Research & Autoimmunity |
Sale or transfer of securities back to the company at price $ 0.00 per share. |
19 Jul 2024 |
200,000 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Mary Beth Harler
|
Head, Research & Autoimmunity |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Jul 2024 |
54,999 |
140,226
(0%)
|
0%
|
|
-
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2024 |
3,078 |
13,124
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2024 |
1,734 |
7,588
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2024 |
2,687 |
46,293
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2024 |
1,734 |
86,588
(0%)
|
0%
|
|
0
|
Common Stock |
Elizabeth H.Z. Thompson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
28 Jun 2024 |
1,452 |
2,904
(0%)
|
0%
|
|
0
|
Common Stock |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 5.02 per share. |
14 Jun 2024 |
3,000 |
97,388
(0%)
|
0%
|
5.0 |
15,060
|
Common Stock |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Sale of securities on an exchange or to another person at price $ 7.58 per share. |
14 Jun 2024 |
1,570 |
95,818
(0%)
|
0%
|
7.6 |
11,893
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
14 Jun 2024 |
977 |
60,029
(0%)
|
0%
|
7.6 |
7,401
|
Common Stock |
Fred Schwarzer
|
Director, CEO AND PRESIDENT |
Sale of securities on an exchange or to another person at price $ 7.58 per share. |
14 Jun 2024 |
4,164 |
254,070
(0%)
|
0%
|
7.6 |
31,544
|
Common Stock |
Fred Schwarzer
|
Director, CEO AND PRESIDENT |
Grant, award, or other acquisition of securities at price $ 5.02 per share. |
14 Jun 2024 |
3,000 |
258,234
(0%)
|
0%
|
5.0 |
15,060
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Sale of securities on an exchange or to another person at price $ 7.58 per share. |
14 Jun 2024 |
1,106 |
197,769
(0%)
|
0%
|
7.6 |
8,378
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 5.02 per share. |
14 Jun 2024 |
3,000 |
198,875
(0%)
|
0%
|
5.0 |
15,060
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
14 Jun 2024 |
1,570 |
88,848
(0%)
|
0%
|
7.6 |
11,893
|
Common Stock |
Steven Weber
|
PRINCIPAL ACCOUNTING OFFICER |
|
14 Jun 2024 |
495 |
26,012
(0%)
|
0%
|
7.6 |
3,750
|
Common Stock |
Mary Beth Harler
|
Head, Research & Autoimmunity |
Sale of securities on an exchange or to another person at price $ 7.58 per share. |
14 Jun 2024 |
1,570 |
85,227
(0%)
|
0%
|
7.6 |
11,893
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Mar 2024 |
3,078 |
10,046
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Mar 2024 |
1,734 |
5,854
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Mar 2024 |
2,687 |
43,606
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Mar 2024 |
1,734 |
84,854
(0%)
|
0%
|
|
0
|
Common Stock |
Elizabeth H.Z. Thompson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Mar 2024 |
1,452 |
1,452
(0%)
|
0%
|
|
0
|
Common Stock |
Fred Schwarzer
|
Director, CEO AND PRESIDENT |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Mar 2024 |
38,583 |
255,234
(0%)
|
0%
|
|
0
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
26 Mar 2024 |
24,019 |
195,875
(0%)
|
0%
|
|
0
|
Common Stock |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Sale of securities on an exchange or to another person at price $ 10.17 per share. |
13 Mar 2024 |
2,535 |
94,388
(0%)
|
0%
|
10.2 |
25,782
|
Common Stock |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Sale of securities on an exchange or to another person at price $ 9.88 per share. |
13 Mar 2024 |
2,889 |
96,923
(0%)
|
0%
|
9.9 |
28,529
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
13 Mar 2024 |
1,798 |
62,584
(0%)
|
0%
|
9.9 |
17,756
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
13 Mar 2024 |
1,578 |
61,006
(0%)
|
0%
|
10.2 |
16,049
|
Common Stock |
Fred Schwarzer
|
Director, CEO AND PRESIDENT |
Sale of securities on an exchange or to another person at price $ 9.88 per share. |
13 Mar 2024 |
4,765 |
220,833
(0%)
|
0%
|
9.9 |
47,055
|
Common Stock |
Fred Schwarzer
|
Director, CEO AND PRESIDENT |
Sale of securities on an exchange or to another person at price $ 10.17 per share. |
13 Mar 2024 |
4,182 |
216,651
(0%)
|
0%
|
10.2 |
42,533
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Sale of securities on an exchange or to another person at price $ 10.17 per share. |
13 Mar 2024 |
1,844 |
171,856
(0%)
|
0%
|
10.2 |
18,754
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Sale of securities on an exchange or to another person at price $ 9.88 per share. |
13 Mar 2024 |
2,101 |
173,700
(0%)
|
0%
|
9.9 |
20,748
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
13 Mar 2024 |
2,543 |
90,418
(0%)
|
0%
|
10.2 |
25,864
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
13 Mar 2024 |
2,897 |
92,961
(0%)
|
0%
|
9.9 |
28,608
|
Common Stock |
Steven Weber
|
PRINCIPAL ACCOUNTING OFFICER |
|
13 Mar 2024 |
464 |
26,507
(0%)
|
0%
|
10.2 |
4,719
|
Common Stock |
Steven Weber
|
PRINCIPAL ACCOUNTING OFFICER |
|
13 Mar 2024 |
529 |
26,971
(0%)
|
0%
|
9.9 |
5,224
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
29,400 |
29,400
|
-
|
|
-
|
Stock Option (right to buy) |
Julie Hambleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
29,400 |
29,400
|
-
|
|
-
|
Stock Option (right to buy) |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
92,500 |
92,500
|
-
|
|
-
|
Stock Option (right to buy) |
Chris H. Takimoto
|
CHIEF MEDICAL OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
46,250 |
99,812
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
29,400 |
29,400
|
-
|
|
-
|
Stock Option (Right to Buy) |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
12 Mar 2024 |
28,750 |
64,382
(0%)
|
0%
|
|
0
|
Common Stock |
Lisa Lynn Decker
|
CHIEF BUSINESS OFFICER |
|
12 Mar 2024 |
57,500 |
57,500
|
-
|
|
-
|
Stock Option (right to buy) |
Fred Schwarzer
|
Director, CEO AND PRESIDENT |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
122,750 |
225,598
(0%)
|
0%
|
|
0
|
Common Stock |
Fred Schwarzer
|
Director, CEO AND PRESIDENT |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
245,500 |
245,500
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
92,500 |
92,500
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
46,250 |
175,801
(0%)
|
0%
|
|
0
|
Common Stock |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
12 Mar 2024 |
92,500 |
92,500
|
-
|
|
-
|
Stock Option (right to buy) |
Misbah Tahir
|
CHIEF FINANCIAL OFFICER |
|
12 Mar 2024 |
46,250 |
95,858
(0%)
|
0%
|
|
0
|
Common Stock |
William Strohl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
29,400 |
29,400
|
-
|
|
-
|
Stock Option (right to buy) |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
29,400 |
29,400
|
-
|
|
-
|
Stock Option (right to buy) |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
29,400 |
29,400
|
-
|
|
-
|
Stock Option (right to buy) |
Steven Weber
|
PRINCIPAL ACCOUNTING OFFICER |
|
12 Mar 2024 |
18,750 |
27,500
(0%)
|
0%
|
|
0
|
Common Stock |
Steven Weber
|
PRINCIPAL ACCOUNTING OFFICER |
|
12 Mar 2024 |
37,500 |
37,500
|
-
|
|
-
|
Stock Option (right to buy) |
Elizabeth H.Z. Thompson
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2024 |
29,400 |
29,400
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
01 Mar 2024 |
3,026 |
4,039
(0%)
|
0%
|
0.9 |
2,814
|
Common Stock |
Bruce Keyt
|
CHIEF SCIENTIFIC OFFICER |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2024 |
3,026 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Behrens Wilsey Kathleen M.
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Dec 2023 |
800 |
6,968
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Dec 2023 |
492 |
4,120
(0%)
|
0%
|
|
0
|
Common Stock |
Teng Christina Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Dec 2023 |
738 |
40,919
(0%)
|
0%
|
|
0
|
Common Stock |
Haldor Topsoe Jakob
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Dec 2023 |
492 |
83,120
(0%)
|
0%
|
|
0
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 5.78 per share. |
13 Dec 2023 |
17,576 |
102,848
(0%)
|
0%
|
5.8 |
101,558
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 5.78 per share. |
13 Dec 2023 |
7,574 |
129,551
(0%)
|
0%
|
5.8 |
43,764
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
13 Dec 2023 |
4,369 |
35,632
(0%)
|
0%
|
5.8 |
25,245
|
Common Stock |
Lynn Lisa Decker
|
Chief Business Officer |
|
29 Nov 2023 |
1,180 |
40,001
(0%)
|
0%
|
6.2 |
7,331
|
11/29/2023 |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 9.42 per share. |
03 Jul 2023 |
936 |
40,017
(0%)
|
0%
|
9.4 |
8,818
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2023 |
800 |
5,368
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2023 |
1,138 |
1,138
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2023 |
492 |
3,136
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 9.32 per share. |
30 Jun 2023 |
3,000 |
9,800
(0%)
|
0%
|
9.3 |
27,957
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2023 |
738 |
39,443
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 9.25 per share. |
29 Jun 2023 |
3,500 |
81,644
(0%)
|
0%
|
9.3 |
32,375
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Jun 2023 |
492 |
82,136
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 9.10 per share. |
29 Jun 2023 |
3,500 |
78,144
(0%)
|
0%
|
9.1 |
31,847
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 8.00 per share. |
26 Jun 2023 |
112,500 |
330,700
(1%)
|
0%
|
8 |
900,000
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
26 Jun 2023 |
1,687,500 |
5,044,295
|
-
|
|
-
|
Non-Voting Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
26 Jun 2023 |
1,687,500 |
5,044,295
|
-
|
|
-
|
Non-Voting Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 13.00 per share. |
23 May 2023 |
15 |
54,742
(0%)
|
0%
|
13 |
195
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 12.30 per share. |
23 May 2023 |
1,244 |
54,757
(0%)
|
0%
|
12.3 |
15,302
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 11.71 per share. |
23 May 2023 |
962 |
56,001
(0%)
|
0%
|
11.7 |
11,265
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
23 May 2023 |
961 |
42,440
(0%)
|
0%
|
11.7 |
11,253
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
23 May 2023 |
15 |
41,181
(0%)
|
0%
|
13 |
195
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
23 May 2023 |
1,244 |
41,196
(0%)
|
0%
|
12.3 |
15,302
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 12.30 per share. |
23 May 2023 |
1,244 |
121,776
(0%)
|
0%
|
12.3 |
15,302
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 11.71 per share. |
23 May 2023 |
960 |
123,020
(0%)
|
0%
|
11.7 |
11,242
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 13.00 per share. |
23 May 2023 |
15 |
121,761
(0%)
|
0%
|
13 |
195
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 11.71 per share. |
23 May 2023 |
960 |
139,040
(0%)
|
0%
|
11.7 |
11,242
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 13.00 per share. |
23 May 2023 |
12 |
138,058
(0%)
|
0%
|
13 |
156
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 12.30 per share. |
23 May 2023 |
970 |
138,070
(0%)
|
0%
|
12.3 |
11,931
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
23 May 2023 |
1,244 |
50,726
(0%)
|
0%
|
12.3 |
15,302
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
23 May 2023 |
15 |
50,711
(0%)
|
0%
|
13 |
195
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
23 May 2023 |
398 |
51,970
(0%)
|
0%
|
11.7 |
4,661
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 13.00 per share. |
23 May 2023 |
15 |
40,953
(0%)
|
0%
|
13 |
195
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 12.30 per share. |
23 May 2023 |
1,244 |
40,968
(0%)
|
0%
|
12.3 |
15,302
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
18 Apr 2023 |
8,497 |
41,479
(0%)
|
0%
|
|
0
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Apr 2023 |
34,200 |
122,060
(0%)
|
0%
|
|
0
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Apr 2023 |
21,126 |
138,080
(0%)
|
0%
|
|
0
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
18 Apr 2023 |
8,334 |
42,212
(0%)
|
0%
|
|
0
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
15,500 |
15,500
|
-
|
|
-
|
Stock Option (right to buy) |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
15,500 |
15,500
|
-
|
|
-
|
Stock Option (right to buy) |
Julie Hambleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
15,500 |
15,500
|
-
|
|
-
|
Stock Option (right to buy) |
Chris H. Takimoto
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
26,250 |
55,039
(0%)
|
0%
|
|
0
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
52,500 |
52,500
|
-
|
|
-
|
Stock Option (right to buy) |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
15,500 |
15,500
|
-
|
|
-
|
Stock Option (Right to Buy) |
Lisa Lynn Decker
|
Chief Business Officer |
|
04 Apr 2023 |
16,250 |
32,982
(0%)
|
0%
|
|
0
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
04 Apr 2023 |
32,500 |
32,500
|
-
|
|
-
|
Stock Option (right to buy) |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
135,000 |
135,000
|
-
|
|
-
|
Stock Option (right to buy) |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
67,500 |
87,860
(0%)
|
0%
|
|
0
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
52,500 |
52,500
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
26,250 |
116,954
(0%)
|
0%
|
|
0
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
04 Apr 2023 |
52,500 |
52,500
|
-
|
|
-
|
Stock Option (right to buy) |
Misbah Tahir
|
Chief Financial Officer |
|
04 Apr 2023 |
26,250 |
51,572
(0%)
|
0%
|
|
0
|
Common Stock |
William Strohl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
15,500 |
15,500
|
-
|
|
-
|
Stock Option (right to buy) |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
15,500 |
15,500
|
-
|
|
-
|
Stock Option (right to buy) |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
15,500 |
15,500
|
-
|
|
-
|
Stock Option (right to buy) |
Steven Weber
|
Principal Accounting Officer |
|
04 Apr 2023 |
8,750 |
8,750
(0%)
|
0%
|
|
0
|
Common Stock |
Steven Weber
|
Principal Accounting Officer |
|
04 Apr 2023 |
17,500 |
17,500
|
-
|
|
-
|
Stock Option (right to buy) |
George Gauthier
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
16,250 |
34,813
(0%)
|
0%
|
|
0
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
04 Apr 2023 |
32,500 |
32,500
|
-
|
|
-
|
Stock Option (right to buy) |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 12.60 per share. |
04 Apr 2023 |
935 |
33,878
(0%)
|
0%
|
12.6 |
11,781
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2023 |
800 |
4,568
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2023 |
1,138 |
1,138
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2023 |
533 |
36,371
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2023 |
533 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2023 |
492 |
2,644
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2023 |
738 |
38,705
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2023 |
492 |
74,644
(0%)
|
0%
|
|
0
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.73 per share. |
14 Mar 2023 |
1,768 |
28,789
(0%)
|
0%
|
18.7 |
33,118
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
14 Mar 2023 |
1,061 |
16,732
(0%)
|
0%
|
18.7 |
19,875
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.73 per share. |
14 Mar 2023 |
1,293 |
90,704
(0%)
|
0%
|
18.7 |
24,220
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
14 Mar 2023 |
1,768 |
25,322
(0%)
|
0%
|
18.7 |
33,118
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 18.73 per share. |
14 Mar 2023 |
1,061 |
18,563
(0%)
|
0%
|
18.7 |
19,875
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Jan 2023 |
33,756 |
0
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
05 Jan 2023 |
33,756 |
91,997
(0%)
|
0%
|
0.9 |
31,393
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2022 |
374 |
3,768
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
30 Dec 2022 |
533 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
30 Dec 2022 |
533 |
35,838
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2022 |
533 |
533
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2022 |
230 |
2,152
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2022 |
346 |
37,967
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Dec 2022 |
230 |
74,152
(0%)
|
0%
|
|
0
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 19.36 per share. |
16 Dec 2022 |
1,938 |
30,557
(0%)
|
0%
|
19.4 |
37,519
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 18.77 per share. |
16 Dec 2022 |
3,492 |
32,495
(0%)
|
0%
|
18.8 |
65,561
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
16 Dec 2022 |
1,598 |
18,679
(0%)
|
0%
|
18.8 |
30,002
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
16 Dec 2022 |
886 |
17,793
(0%)
|
0%
|
19.4 |
17,153
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 19.36 per share. |
16 Dec 2022 |
4,414 |
20,360
(0%)
|
0%
|
19.4 |
85,453
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 18.77 per share. |
16 Dec 2022 |
7,955 |
24,774
(0%)
|
0%
|
18.8 |
149,352
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 18.77 per share. |
16 Dec 2022 |
3,454 |
60,158
(0%)
|
0%
|
18.8 |
64,847
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 19.36 per share. |
16 Dec 2022 |
1,917 |
58,241
(0%)
|
0%
|
19.4 |
37,112
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
16 Dec 2022 |
815 |
30,891
(0%)
|
0%
|
19.4 |
15,778
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
16 Dec 2022 |
3,801 |
27,090
(0%)
|
0%
|
20 |
76,020
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
16 Dec 2022 |
1,468 |
31,706
(0%)
|
0%
|
18.8 |
27,561
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 18.77 per share. |
16 Dec 2022 |
2,800 |
21,178
(0%)
|
0%
|
18.8 |
52,569
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 19.36 per share. |
16 Dec 2022 |
1,554 |
19,624
(0%)
|
0%
|
19.4 |
30,085
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 21.99 per share. |
23 Nov 2022 |
277 |
35,987
(0%)
|
0%
|
22.0 |
6,092
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 21.38 per share. |
23 Nov 2022 |
600 |
36,264
(0%)
|
0%
|
21.4 |
12,826
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
23 Nov 2022 |
397 |
20,277
(0%)
|
0%
|
22.0 |
8,731
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
23 Nov 2022 |
861 |
20,674
(0%)
|
0%
|
21.4 |
18,405
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 21.99 per share. |
23 Nov 2022 |
397 |
32,729
(0%)
|
0%
|
22.0 |
8,731
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 21.38 per share. |
23 Nov 2022 |
861 |
33,126
(0%)
|
0%
|
21.4 |
18,405
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 21.99 per share. |
23 Nov 2022 |
277 |
38,612
(0%)
|
0%
|
22.0 |
6,092
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 21.38 per share. |
23 Nov 2022 |
600 |
38,889
(0%)
|
0%
|
21.4 |
12,826
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
23 Nov 2022 |
277 |
33,174
(0%)
|
0%
|
22.0 |
6,092
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
23 Nov 2022 |
600 |
33,451
(0%)
|
0%
|
21.4 |
12,826
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
23 Nov 2022 |
353 |
34,051
(0%)
|
0%
|
12.8 |
4,533
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 21.99 per share. |
23 Nov 2022 |
397 |
23,978
(0%)
|
0%
|
22.0 |
8,731
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 21.38 per share. |
23 Nov 2022 |
861 |
24,375
(0%)
|
0%
|
21.4 |
18,405
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 17.14 per share. |
08 Nov 2022 |
60,000 |
218,200
(0%)
|
0%
|
17.1 |
1,028,550
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 22.84 per share. |
04 Oct 2022 |
25,000 |
39,489
(0%)
|
0%
|
22.8 |
570,980
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Oct 2022 |
25,000 |
58,756
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
04 Oct 2022 |
25,000 |
64,489
(0%)
|
0%
|
0.9 |
23,250
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2022 |
374 |
3,394
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2022 |
230 |
1,922
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2022 |
346 |
37,621
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2022 |
230 |
73,922
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
29 Sep 2022 |
533 |
533
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Purchase of securities on an exchange or from another person at price $ 19.62 per share. |
29 Sep 2022 |
5,821 |
35,305
(0%)
|
0%
|
19.6 |
114,213
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
27 Sep 2022 |
533 |
22,805
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Purchase of securities on an exchange or from another person at price $ 20.97 per share. |
27 Sep 2022 |
6,172 |
29,484
(0%)
|
0%
|
21.0 |
129,403
|
Common Stock |
Michael D. Loberg
|
Director |
Purchase of securities on an exchange or from another person at price $ 19.99 per share. |
27 Sep 2022 |
507 |
23,312
(0%)
|
0%
|
20.0 |
10,137
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
27 Sep 2022 |
533 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 19.06 per share. |
06 Sep 2022 |
5,000 |
39,489
(0%)
|
0%
|
19.1 |
95,321
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Sep 2022 |
10,000 |
83,756
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Sep 2022 |
10,000 |
93,756
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
06 Sep 2022 |
5,000 |
103,756
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 20.34 per share. |
06 Sep 2022 |
2,735 |
39,489
(0%)
|
0%
|
20.3 |
55,632
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 19.57 per share. |
06 Sep 2022 |
7,265 |
42,224
(0%)
|
0%
|
19.6 |
142,196
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
06 Sep 2022 |
10,000 |
49,489
(0%)
|
0%
|
0.9 |
9,300
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 19.04 per share. |
06 Sep 2022 |
10,000 |
39,489
(0%)
|
0%
|
19.0 |
190,392
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
06 Sep 2022 |
10,000 |
49,489
(0%)
|
0%
|
0.9 |
9,300
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
06 Sep 2022 |
5,000 |
44,489
(0%)
|
0%
|
0.9 |
4,650
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
18 Aug 2022 |
6,300 |
45,789
(0%)
|
0%
|
0.9 |
5,859
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
18 Aug 2022 |
10,000 |
49,489
(0%)
|
0%
|
0.9 |
9,300
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 22.54 per share. |
18 Aug 2022 |
10,000 |
39,489
(0%)
|
0%
|
22.5 |
225,352
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
18 Aug 2022 |
8,700 |
48,189
(0%)
|
0%
|
0.9 |
8,091
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 22.82 per share. |
18 Aug 2022 |
8,700 |
39,489
(0%)
|
0%
|
22.8 |
198,544
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 20.71 per share. |
18 Aug 2022 |
6,300 |
39,489
(0%)
|
0%
|
20.7 |
130,451
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Aug 2022 |
10,000 |
123,756
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Aug 2022 |
8,700 |
115,056
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
18 Aug 2022 |
6,300 |
108,756
|
-
|
|
-
|
Stock Option (right to buy) |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2022 |
374 |
3,020
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2022 |
533 |
533
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
30 Jun 2022 |
533 |
22,272
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
30 Jun 2022 |
533 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2022 |
230 |
1,692
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2022 |
346 |
37,275
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2022 |
230 |
73,692
(0%)
|
0%
|
|
0
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
26 May 2022 |
950 |
33,698
(0%)
|
0%
|
17.1 |
16,247
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 17.10 per share. |
24 May 2022 |
938 |
36,864
(0%)
|
0%
|
17.1 |
16,043
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
24 May 2022 |
1,362 |
21,535
(0%)
|
0%
|
17.1 |
23,293
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Sale of securities on an exchange or to another person at price $ 17.10 per share. |
24 May 2022 |
1,362 |
33,987
(0%)
|
0%
|
17.1 |
23,294
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 17.10 per share. |
24 May 2022 |
939 |
39,489
(0%)
|
0%
|
17.1 |
16,058
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Sale of securities on an exchange or to another person at price $ 17.10 per share. |
24 May 2022 |
1,340 |
25,236
(0%)
|
0%
|
17.1 |
22,917
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 16.00 per share. |
20 May 2022 |
1,481 |
73,462
(0%)
|
0%
|
16 |
23,696
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 12.38 per share. |
13 May 2022 |
825 |
37,802
(0%)
|
0%
|
12.4 |
10,214
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
13 May 2022 |
413 |
22,897
(0%)
|
0%
|
12.4 |
5,113
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 12.38 per share. |
13 May 2022 |
414 |
35,349
(0%)
|
0%
|
12.4 |
5,125
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 12.38 per share. |
13 May 2022 |
413 |
40,428
(0%)
|
0%
|
12.4 |
5,113
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
13 May 2022 |
391 |
34,648
(0%)
|
0%
|
12.4 |
4,841
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 12.38 per share. |
13 May 2022 |
413 |
26,576
(0%)
|
0%
|
12.4 |
5,113
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 14.08 per share. |
12 May 2022 |
2,290 |
2,290
(0%)
|
0%
|
14.1 |
32,248
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 14.99 per share. |
12 May 2022 |
4,510 |
6,800
(0%)
|
0%
|
15.0 |
67,593
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 14.17 per share. |
12 May 2022 |
8,254 |
64,131
(0%)
|
0%
|
14.2 |
116,991
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 14.86 per share. |
12 May 2022 |
7,850 |
71,981
(0%)
|
0%
|
14.9 |
116,683
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
01 Apr 2022 |
1,086,957 |
3,356,795
|
-
|
|
-
|
Non-Voting Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
01 Apr 2022 |
1,086,957 |
3,356,795
|
-
|
|
-
|
Non-Voting Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 23.00 per share. |
31 Mar 2022 |
8,696 |
29,807
(0%)
|
0%
|
23 |
200,008
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
374 |
2,646
(0%)
|
0%
|
|
0
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 23.00 per share. |
31 Mar 2022 |
43,478 |
158,200
(0%)
|
0%
|
23 |
999,994
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 23.00 per share. |
31 Mar 2022 |
8,695 |
29,806
(0%)
|
0%
|
23 |
199,985
|
Common Stock |
Michael D. Loberg
|
Director |
Purchase of securities on an exchange or from another person at price $ 23.00 per share. |
31 Mar 2022 |
21,739 |
21,739
(0%)
|
0%
|
23 |
499,997
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
533 |
533
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2022 |
300 |
600
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2022 |
300 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
230 |
1,462
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
346 |
36,929
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2022 |
230 |
55,877
(0%)
|
0%
|
|
0
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2022 |
14,477 |
36,977
(0%)
|
0%
|
|
0
|
Common Stock |
Lisa Lynn Decker
|
Chief Business Officer |
|
15 Mar 2022 |
4,617 |
22,484
(0%)
|
0%
|
|
0
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2022 |
23,002 |
34,935
(0%)
|
0%
|
|
0
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2022 |
14,319 |
40,015
(0%)
|
0%
|
|
0
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
15 Mar 2022 |
6,084 |
34,257
(0%)
|
0%
|
|
0
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
15 Mar 2022 |
8,096 |
26,163
(0%)
|
0%
|
|
0
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
29,497 |
29,497
|
-
|
|
-
|
Stock Option (right to buy) |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
29,497 |
29,497
|
-
|
|
-
|
Stock Option (right to buy) |
Julie Hambleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
29,497 |
29,497
|
-
|
|
-
|
Stock Option (right to buy) |
Chris H. Takimoto
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
12,500 |
22,500
(0%)
|
0%
|
|
0
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
75,000 |
75,000
|
-
|
|
-
|
Stock Option (right to buy) |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
29,497 |
29,497
|
-
|
|
-
|
Stock Option (Right to Buy) |
Lisa Lynn Decker
|
Chief Business Officer |
|
12 Mar 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
Lisa Lynn Decker
|
Chief Business Officer |
|
12 Mar 2022 |
7,500 |
17,867
(0%)
|
0%
|
|
0
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
350,000 |
350,000
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
75,000 |
75,000
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
12,500 |
25,696
(0%)
|
0%
|
|
0
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
12 Mar 2022 |
12,500 |
28,173
(0%)
|
0%
|
|
0
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
12 Mar 2022 |
75,000 |
75,000
|
-
|
|
-
|
Stock Option (right to buy) |
William Strohl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
29,497 |
29,497
|
-
|
|
-
|
Stock Option (right to buy) |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
29,497 |
29,497
|
-
|
|
-
|
Stock Option (right to buy) |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
29,497 |
29,497
|
-
|
|
-
|
Stock Option (right to buy) |
George Gauthier
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
7,500 |
18,067
(0%)
|
0%
|
|
0
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
12 Mar 2022 |
45,000 |
45,000
|
-
|
|
-
|
Stock Option (right to buy) |
Lisa Lynn Decker
|
Chief Business Officer |
|
15 Nov 2021 |
367 |
367
(0%)
|
0%
|
51.0 |
18,713
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 50.99 per share. |
15 Nov 2021 |
233 |
1,933
(0%)
|
0%
|
51.0 |
11,881
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 50.99 per share. |
15 Nov 2021 |
139 |
3,196
(0%)
|
0%
|
51.0 |
7,088
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
15 Nov 2021 |
86 |
5,673
(0%)
|
0%
|
51.0 |
4,385
|
Common Stock |
George Gauthier
|
Chief Commercial Officer |
Grant, award, or other acquisition of securities at price $ 50.99 per share. |
15 Nov 2021 |
367 |
567
(0%)
|
0%
|
51.0 |
18,713
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.78 per share. |
01 Nov 2021 |
1,174 |
4,383
(0%)
|
0%
|
49.8 |
58,442
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Nov 2021 |
2,500 |
264
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 51.37 per share. |
01 Nov 2021 |
1,326 |
3,057
(0%)
|
0%
|
51.4 |
68,117
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
01 Nov 2021 |
2,500 |
5,557
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.91 per share. |
01 Oct 2021 |
1,258 |
4,299
(0%)
|
0%
|
65.9 |
82,915
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2021 |
2,500 |
2,764
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 64.10 per share. |
01 Oct 2021 |
1,242 |
3,057
(0%)
|
0%
|
64.1 |
79,617
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
01 Oct 2021 |
2,500 |
5,557
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2021 |
211 |
2,061
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2021 |
300 |
300
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
30 Sep 2021 |
300 |
12,996
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
30 Sep 2021 |
300 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2021 |
130 |
1,102
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2021 |
195 |
36,388
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Sep 2021 |
130 |
55,517
(0%)
|
0%
|
|
0
|
Common Stock |
Julie Hambleton
|
Director |
Sale of securities on an exchange or to another person at price $ 80.00 per share. |
09 Aug 2021 |
1,000 |
2,000
(0%)
|
0%
|
80 |
80,000
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 67.00 per share. |
02 Aug 2021 |
1,242 |
3,057
(0%)
|
0%
|
67 |
83,214
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Aug 2021 |
2,500 |
7,764
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 66.96 per share. |
02 Aug 2021 |
1,258 |
4,299
(0%)
|
0%
|
67.0 |
84,236
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
02 Aug 2021 |
2,500 |
5,557
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
Chris H. Takimoto
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jul 2021 |
150,000 |
150,000
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
01 Jul 2021 |
1,900 |
118,418
(0%)
|
0%
|
1.4 |
2,641
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2021 |
1,900 |
338,340
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 82.75 per share. |
01 Jul 2021 |
943 |
116,518
(0%)
|
0%
|
82.7 |
78,033
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.43 per share. |
01 Jul 2021 |
957 |
117,461
(0%)
|
0%
|
89.4 |
85,585
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.43 per share. |
01 Jul 2021 |
1,253 |
4,304
(0%)
|
0%
|
89.4 |
112,056
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
01 Jul 2021 |
2,500 |
5,557
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jul 2021 |
2,500 |
10,264
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 82.50 per share. |
01 Jul 2021 |
1,247 |
3,057
(0%)
|
0%
|
82.5 |
102,878
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
30 Jun 2021 |
130 |
972
(0%)
|
0%
|
|
0
|
Common Stock |
Julie Hambleton
|
Director |
Sale of securities on an exchange or to another person at price $ 80.00 per share. |
01 Jun 2021 |
2,000 |
3,000
(0%)
|
0%
|
80 |
160,000
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
01 Jun 2021 |
1,900 |
118,418
(0%)
|
0%
|
1.4 |
2,641
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2021 |
1,900 |
340,240
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 79.15 per share. |
01 Jun 2021 |
941 |
116,518
(0%)
|
0%
|
79.1 |
74,480
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.99 per share. |
01 Jun 2021 |
959 |
117,459
(0%)
|
0%
|
80.0 |
76,710
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
01 Jun 2021 |
2,500 |
5,557
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Jun 2021 |
2,500 |
12,764
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 79.15 per share. |
01 Jun 2021 |
1,245 |
3,057
(0%)
|
0%
|
79.2 |
98,542
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.99 per share. |
01 Jun 2021 |
1,255 |
4,302
(0%)
|
0%
|
80.0 |
100,387
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 70.00 per share. |
26 May 2021 |
444 |
116,518
(0%)
|
0%
|
70 |
31,080
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 45.90 per share. |
14 May 2021 |
313 |
1,700
(0%)
|
0%
|
45.9 |
14,367
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
14 May 2021 |
900 |
342,140
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
14 May 2021 |
900 |
117,418
(0%)
|
0%
|
1.4 |
1,251
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.76 per share. |
14 May 2021 |
456 |
116,962
(0%)
|
0%
|
68.8 |
31,355
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 45.90 per share. |
14 May 2021 |
288 |
3,057
(0%)
|
0%
|
45.9 |
13,219
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
14 May 2021 |
45 |
5,587
(0%)
|
0%
|
45.9 |
2,066
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 62.32 per share. |
05 May 2021 |
469 |
116,518
(0%)
|
0%
|
62.3 |
29,226
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 May 2021 |
950 |
343,040
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
03 May 2021 |
950 |
117,468
(0%)
|
0%
|
1.4 |
1,321
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.03 per share. |
03 May 2021 |
481 |
116,987
(0%)
|
0%
|
68.0 |
32,722
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 62.50 per share. |
03 May 2021 |
1,243 |
2,769
(0%)
|
0%
|
62.5 |
77,688
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
03 May 2021 |
2,500 |
5,269
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.03 per share. |
03 May 2021 |
1,257 |
4,012
(0%)
|
0%
|
68.0 |
85,514
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
03 May 2021 |
2,500 |
15,264
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.40 per share. |
05 Apr 2021 |
678 |
117,740
(0%)
|
0%
|
83.4 |
56,545
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 82.00 per share. |
05 Apr 2021 |
1,222 |
116,518
(0%)
|
0%
|
82 |
100,204
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
05 Apr 2021 |
1,900 |
118,418
(0%)
|
0%
|
1.4 |
2,641
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Apr 2021 |
1,900 |
343,990
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
05 Apr 2021 |
2,500 |
17,764
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 82.00 per share. |
05 Apr 2021 |
1,254 |
2,769
(0%)
|
0%
|
82 |
102,828
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 83.40 per share. |
05 Apr 2021 |
1,246 |
4,023
(0%)
|
0%
|
83.4 |
103,916
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
05 Apr 2021 |
2,500 |
5,269
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2021 |
211 |
94,139
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2021 |
535 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2021 |
300 |
300
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
31 Mar 2021 |
535 |
2,140
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2021 |
130 |
842
(0%)
|
0%
|
|
0
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2021 |
195 |
35,998
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
31 Mar 2021 |
130 |
55,257
(0%)
|
0%
|
|
0
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
05 Mar 2021 |
2,750 |
120,097
|
-
|
|
-
|
Stock Option (right to buy) |
Misbah Tahir
|
Chief Financial Officer |
|
05 Mar 2021 |
2,750 |
5,542
(0%)
|
0%
|
1.4 |
3,823
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
01 Mar 2021 |
1,900 |
118,418
(0%)
|
0%
|
1.4 |
2,641
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 90.25 per share. |
01 Mar 2021 |
1,224 |
116,518
(0%)
|
0%
|
90.3 |
110,466
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2021 |
1,900 |
345,890
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.44 per share. |
01 Mar 2021 |
676 |
117,742
(0%)
|
0%
|
92.4 |
62,489
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
01 Mar 2021 |
2,500 |
5,269
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Mar 2021 |
2,500 |
20,264
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 90.25 per share. |
01 Mar 2021 |
1,619 |
2,769
(0%)
|
0%
|
90.3 |
146,115
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 92.44 per share. |
01 Mar 2021 |
881 |
4,388
(0%)
|
0%
|
92.4 |
81,440
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
6,423 |
6,423
|
-
|
|
-
|
Stock Option (right to buy) |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
6,423 |
6,423
|
-
|
|
-
|
Stock Option (right to buy) |
Julie Hambleton
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
6,423 |
6,423
|
-
|
|
-
|
Stock Option (right to buy) |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
6,423 |
6,423
|
-
|
|
-
|
Stock Option (Right to Buy) |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
125,000 |
125,000
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
50,000 |
50,000
|
-
|
|
-
|
Stock Option (right to buy) |
Misbah Tahir
|
Chief Financial Officer |
|
19 Feb 2021 |
40,000 |
40,000
|
-
|
|
-
|
Stock Option (right to buy) |
William Strohl
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
6,423 |
6,423
|
-
|
|
-
|
Stock Option (right to buy) |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
6,423 |
6,423
|
-
|
|
-
|
Stock Option (right to buy) |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
19 Feb 2021 |
6,423 |
6,423
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.40 per share. |
02 Feb 2021 |
674 |
117,699
(0%)
|
0%
|
96.4 |
64,974
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Feb 2021 |
1,900 |
347,790
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 96.00 per share. |
02 Feb 2021 |
1,226 |
116,473
(0%)
|
0%
|
96 |
117,696
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
02 Feb 2021 |
1,900 |
118,373
(0%)
|
0%
|
1.4 |
2,641
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 96.40 per share. |
02 Feb 2021 |
881 |
4,388
(0%)
|
0%
|
96.4 |
84,928
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
02 Feb 2021 |
2,500 |
5,269
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Feb 2021 |
2,500 |
22,764
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 96.00 per share. |
02 Feb 2021 |
1,619 |
2,769
(0%)
|
0%
|
96 |
155,424
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.27 per share. |
04 Jan 2021 |
798 |
117,575
(0%)
|
0%
|
77.3 |
61,661
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jan 2021 |
1,900 |
349,690
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 79.25 per share. |
04 Jan 2021 |
1,102 |
116,473
(0%)
|
0%
|
79.3 |
87,334
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
04 Jan 2021 |
1,900 |
118,373
(0%)
|
0%
|
1.4 |
2,641
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
04 Jan 2021 |
2,500 |
5,269
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 88.07 per share. |
04 Jan 2021 |
883 |
1,013
(0%)
|
0%
|
88.1 |
77,766
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
04 Jan 2021 |
2,500 |
25,264
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 79.33 per share. |
04 Jan 2021 |
1,503 |
2,769
(0%)
|
0%
|
79.3 |
119,233
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 77.27 per share. |
04 Jan 2021 |
997 |
4,272
(0%)
|
0%
|
77.3 |
77,038
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
21 Dec 2020 |
2,750 |
122,847
|
-
|
|
-
|
Stock Option (right to buy) |
Misbah Tahir
|
Chief Financial Officer |
|
21 Dec 2020 |
2,750 |
2,792
(0%)
|
0%
|
1.4 |
3,823
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 86.10 per share. |
16 Dec 2020 |
1,618 |
2,769
(0%)
|
0%
|
86.1 |
139,310
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 89.38 per share. |
16 Dec 2020 |
882 |
4,387
(0%)
|
0%
|
89.4 |
78,833
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
16 Dec 2020 |
2,500 |
27,764
|
-
|
|
-
|
Stock Option (right to buy) |
Bruce Keyt
|
Chief Scientific Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.93 per share. |
16 Dec 2020 |
2,500 |
5,269
(0%)
|
0%
|
0.9 |
2,325
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 90.00 per share. |
11 Dec 2020 |
11,111 |
21,111
(0%)
|
0%
|
90 |
999,990
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 90.00 per share. |
11 Dec 2020 |
11,111 |
21,111
(0%)
|
0%
|
90 |
999,990
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 90.00 per share. |
11 Dec 2020 |
22,222 |
22,222
(0%)
|
0%
|
90 |
1,999,980
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 90.00 per share. |
11 Dec 2020 |
111,111 |
10,400,564
(34%)
|
0%
|
90 |
9,999,990
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 90.00 per share. |
11 Dec 2020 |
111,111 |
10,400,564
(34%)
|
0%
|
90 |
9,999,990
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 72.92 per share. |
07 Dec 2020 |
681 |
117,692
(0%)
|
0%
|
72.9 |
49,659
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
07 Dec 2020 |
1,900 |
351,590
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 91.00 per share. |
07 Dec 2020 |
1,219 |
116,473
(0%)
|
0%
|
91 |
110,929
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
07 Dec 2020 |
1,900 |
118,373
(0%)
|
0%
|
1.4 |
2,641
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
01 Dec 2020 |
950 |
117,423
(0%)
|
0%
|
1.4 |
1,321
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Dec 2020 |
950 |
353,490
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 63.15 per share. |
01 Dec 2020 |
608 |
116,473
(0%)
|
0%
|
63.2 |
38,398
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 64.22 per share. |
01 Dec 2020 |
342 |
117,081
(0%)
|
0%
|
64.2 |
21,963
|
Common Stock |
Fred Schwarzer
|
Director, CEO and President |
Grant, award, or other acquisition of securities at price $ 45.45 per share. |
13 Nov 2020 |
291 |
198,105
(0%)
|
0%
|
45.5 |
13,226
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Grant, award, or other acquisition of securities at price $ 45.45 per share. |
13 Nov 2020 |
132 |
2,769
(0%)
|
0%
|
45.4 |
5,999
|
Common Stock |
Misbah Tahir
|
Chief Financial Officer |
|
13 Nov 2020 |
42 |
42
(0%)
|
0%
|
45.5 |
1,909
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
02 Nov 2020 |
950 |
117,468
(0%)
|
0%
|
1.4 |
1,321
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
02 Nov 2020 |
950 |
354,440
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 50.00 per share. |
02 Nov 2020 |
605 |
116,473
(0%)
|
0%
|
50 |
30,250
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.39 per share. |
02 Nov 2020 |
345 |
117,123
(0%)
|
0%
|
52.4 |
18,075
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Oct 2020 |
357 |
93,571
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Oct 2020 |
535 |
535
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
01 Oct 2020 |
535 |
1,070
(0%)
|
0%
|
|
0
|
Common Stock |
Michael D. Loberg
|
Director |
Gift of securities by or to the insider at price $ 0.00 per share. |
01 Oct 2020 |
535 |
0
(0%)
|
0%
|
|
0
|
Common Stock |
Michael Lee
|
Director |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Oct 2020 |
178 |
534
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 73.50 per share. |
01 Oct 2020 |
1,830 |
116,518
(0%)
|
0%
|
73.5 |
134,505
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
01 Oct 2020 |
2,850 |
119,368
(0%)
|
0%
|
1.4 |
3,962
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
01 Oct 2020 |
2,850 |
355,390
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 76.13 per share. |
01 Oct 2020 |
1,020 |
118,348
(0%)
|
0%
|
76.1 |
77,653
|
Common Stock |
Bruce Keyt
|
Chief Scientific Officer |
Sale of securities on an exchange or to another person at price $ 73.59 per share. |
01 Oct 2020 |
1,000 |
1,896
(0%)
|
0%
|
73.6 |
73,590
|
Common Stock |
Christina Teng Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Oct 2020 |
357 |
35,446
(0%)
|
0%
|
|
0
|
Common Stock |
Jakob Haldor Topsoe
|
Director, Ten Percent Owner |
Grant, award, or other acquisition of securities at price $ 0.00 per share. |
01 Oct 2020 |
178 |
54,949
(0%)
|
0%
|
|
0
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.39 per share. |
17 Sep 2020 |
950 |
117,468
(0%)
|
0%
|
1.4 |
1,321
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. |
17 Sep 2020 |
950 |
358,240
|
-
|
|
-
|
Stock Option (right to buy) |
Daniel Chen
|
Chief Medical Officer |
Sale of securities on an exchange or to another person at price $ 77.91 per share. |
17 Sep 2020 |
609 |
116,518
(0%)
|
0%
|
77.9 |
47,447
|
Common Stock |
Daniel Chen
|
Chief Medical Officer |
Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.14 per share. |
17 Sep 2020 |
341 |
117,127
(0%)
|
0%
|
71.1 |
24,259
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 63.06 per share. |
10 Sep 2020 |
2,791 |
88,293
(0%)
|
0%
|
63.1 |
176,004
|
Common Stock |
M. Kathleen Behrens Wilsey
|
Director |
Purchase of securities on an exchange or from another person at price $ 56.41 per share. |
10 Sep 2020 |
978 |
64,192
(0%)
|
0%
|
56.4 |
55,165
|
Common Stock |